August 24, 2020
RFA-DK-20-002 - NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
This Notice provides details for applicants extending the reporting requirements for pilot project program outcomes for renewal applications. The following section of the FOA is revised accordingly:
Part 2. Section IV Application and Submission Information, Pilot and Feasibility Program, Research and Related Other Project Information (Pilot and Feasibility Program)
Current Language
Pilot Project Outcomes (Required for renewal applications only): Please title this attachment "Pilot Projects Outcomes" and list all Pilot Projects supported in full, or in part, by the CDTR. Provide information on the most recent 5-year period. Include the years funded, awardee, dates, and amount of P and F funding, pilot project title, P and F award type (i.e., new investigator; established investigator), abstracts derived from pilot support, resulting grants funded or pending applications (including grant number/funding agency and project period), and whether the P and F awardee is still involved in Diabetes translation research. Table E is provided at CDTR Application Resources for assistance with this requirement.
Revised Language
Pilot Project Outcomes (Required for renewal applications only): Please title this attachment "Pilot Projects Outcomes" and list all Pilot Projects supported in full, or in part, by the CDTR. Provide information on the most recent 5-year period, and if applicable, 10-year period. Include the years funded, awardee, dates, and amount of P and F funding, pilot project title, P and F award type (i.e., new investigator; established investigator), abstracts derived from pilot support, resulting grants funded or pending applications (including grant number/funding agency and project period), and whether the P and F awardee is still involved in Diabetes translation research. Table E is provided at CDTR Application Resources for assistance with this requirement.
All other aspects of this FOA remain the same.
Pamela L. Thornton, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-6476
Email: [email protected]